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Stroke represents a common pathology with potentially heavily debilitating 
or lethal consequences if untreated. The last two decades witnessed a 
remarkable development of therapeutic options for ischemic stroke, the 
most frequent subtype of cerebrovascular accident. Current therapeutic 
options include both medical treatment and minimally invasive mechanical 
thrombectomy. The goal of the latter, a new modality of interventional 
stroke therapy, is to revascularize ischemic yet not completely infarcted 
brain tissue via endovascular mechanical removal of the thrombus.  
The progress in techniques and methods led to remarkable improvement 
of outcome in stroke patients (Balucani et al. 2016; Evans et al. 2017). 
Parallel to the evolution of interventional stroke treatment, there has been 
a development in revascularization grading, utilized to assess the success 
of mechanical embolectomy of large vessel occlusion. Several gradings 
are available and the most commonly adopted is the “modified treatment 
in cerebral ischemia” (mTICI). Although the mTICI scale represents a 
practical and relatively simple scale easily applied in everyday clinical 
practice, it shows a considerable lack of predictability of clinical outcome 
in middle to high percentages of revascularization of ischemic territory. In 
order to overcome this limitation we investigate a new angiographic 
revascularization grading, named “expanded treatment in cerebral 
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ischemia” (eTICI), and we compare the ability of the newly introduced 
eTICI to the mTICI angiographic revascularization grading in predicting the 
clinical neurological outcome and functional independence after 
endovascular treatment of large vessel occlusion in a real world cohort. 
Moreover, the influence of time on the angiographic outcome (eTICI) after 
endovascular treatment will be examined.  
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2.1  Stroke 
 
 
2.1.1 Ischemic Stroke 
 
Cerebrovascular disease can be best defined as an “acute neurologic 
dysfunction of vascular origin with sudden or rapid occurrence of 
symptoms and signs corresponding to the involvement of focal areas in 
the brain” (Goldstein et al. 1989).  
Stroke is an extremely common pathology, representing the leading 
mortality cause in the female and the second after coronary artery disease 
in the male gender in industrialized nations (11 % of the total) (Allen and 
Bayraktutan 2008; Kalaria 2012; Arboix 2015). Cerebrovascular insult is 
furthermore the major reason of lost disability-adjusted life-years in adults 
in first world countries (Vidale and Agostoni 2017). Circa 90 % of patients 
affected by stroke present residual and permanent neurological deficits. 
About 30 % of these patients are so heavily affected, that they cannot 
return to their previous usual activities at the same degree of  
independence as before the cerebrovascular insult (Kalaria 2012; Arboix 
2015). Stroke also represents an important etiology of mental impairment 
and dementia (Allen and Bayraktutan 2008; Arboix 2015). 
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2.1.2 Etiology and pathophysiology 
 
Stroke is a multifactorial disease and several risk factors play a significant 
role in its etiology. These are typically classified in “non-modifiable” and 
“modifiable”. The first ones mainly include inherited diseases, gender and 
age, while the latter can be at least partially influenced by the lifestyle 
(diabetes mellitus, arterial hypertension, carotid stenosis, smoking and 
substance abuse including alcohol, dyslipidemia, obesity, metabolic 
syndrome among others) (Marrugat et al. 2007; Allen and Bayraktutan 
2008; ESO 2008; Arboix 2015). 
Two major subtypes of stroke can be distinguished: hemorrhagic (15 – 20 
%) and ischemic stroke (80 – 85 %) (Lopez et al. 2006). The ischemic 
cerebrovascular accident is a very diverse pathological and clinical 
condition, accounting for several causes and a broad spectrum of 
neurological appearances. The majority of ischemic cerebrovascular 
accidents (almost 50 %) have an arterial thrombotic origin. Concerning the 
remaining half ca. 20 % have an embolic etiology, 5 - 10 % are watershed 
strokes (caused by cardiac insufficiency or severely low blood pressure), 
while the rest have different (such as tumor compression, cerebral venous 
thrombosis) or unknown origin (Hinkle and Guanci 2007). In a thrombotic 
cerebrovascular accident, an injury of the endothelium of the arteries 
supplying the brain leads to plaque and thrombus formation along the 
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injured vessel. The damage of the tunica intima activates the 
thrombocytes’ adhesion and aggregation, followed by the coagulation 
cascade and eventually the development of a thrombus. The thrombotic 
formation may cause an arterial flow reduction, while the collateral 
circulation may maintain its function and compensate the flow drop. 
However, if the compensation of collateralization is insufficient or 
disrupted, brain perfusion is decreased or even abolished in the supply 
territory of the thrombosed artery, leading to cerebral ischemia and, if the 
process is not reversed, eventually cell death (Hinkle and Guanci 2007). 
In the event of an embolic stroke, an embolus originates outside the 
intracranial circulation and is then transported via the blood circulation to 
the brain, where it wedges within the cerebral arteries. An embolus often 
has a thrombotic origin (thromboembolus), detaching from an 
atherosclerotic plaque in the internal carotid artery. Emboli can moreover 
have a cardiac genesis (often because of cardiac arrhythmias or 
endocarditis) or a venous origin (deep vein thrombosis with thromboemboli 
moving from venous to arterial circulation through a patent foramen ovale) 
(Hinkle and Guanci 2007). Surgical and interventional procedures may 
cause fat, gas or thromboembolism, particularly during major surgery or 
endovascular procedures. Other less frequent etiologies of 
cerebrovascular insult comprise carotid dissection (Blum and Yaghi 2015) 
and the presence of coagulation disorders (Levine et al. 2004). Further 
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rarer yet clinically relevant etiologies are vasculitis, infectious diseases 
and intravenous substance abuse (Blank-Reid 1996).  
Independently from its etiology, in the event of an ischemic 
cerebrovascular accident, a sudden interruption or relevant decrease in 
blood supply to a cerebral area occurs. The consequent glucose and 
oxygen deprivation impair the normal function of brain cells, which cannot 
perform aerobic metabolism and, unlike other tissues, are unable to switch 
to anaerobic metabolism due to the lack of any long-term energy storage, 
making the brain particularly vulnerable to ischemia. The adenosine 
triphosphate (ATP) supply is rapidly depleted (usually within 4 minutes), 
leading to loss of ability to maintain electrochemical gradients, impairment 
of disposal of metabolic waste, lipolysis, the arrest of protein synthesis and 
eventually cell death (Lee et al. 2000). Furthermore, solid evidence 
indicates that the blood supply and the lack of metabolites limitations are 
only a part of the equation in the cerebral damage due to ischemia. The 
brain’s signaling pathways, which under normal conditions serve for 
physiological inter- and intracellular communication, can precipitate the 
effects of ischemia by  exacerbating the energetic depletion and fostering 
the chemical pathways involved in neuronal and glial death (including but 
not limited to reactive oxygen species, inflammation, insufficiency of 
membrane pumps, activation of proteases, nucleases, lipases, caspases 
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and apoptosis) (Choi 1988; Obrenovitch and Richards 1995; Lee et al. 
1999; Lee et al. 2000; Hinkle and Guanci 2007).  
Comprehension of etiology/pathophysiology as well as of the rapid 
dynamics of the cerebral ischemic event contributed to the development 
of a “therapeutic timespan” for stroke treatment. Within the ischemic 
cerebrovascular bed, two major injury areas can often be distinguished: 
the infarct core and the “penumbra”, an area of surrounding ischemic, 
hypoperfused but not fully infarcted brain tissue, which can potentially be 
rescued via intra-venous or interventional treatment (Kaufmann et al. 
1999; Yu et al. 2016). A higher volume of penumbra around a cerebral 
infarction indicates a greater volume of potentially salvageable brain tissue  
(Herholz and Heiss 2000).  
      
 
2.1.3 Signs and symptoms 
 
In the acute setting, a potential stroke is handled as a medical emergency. 
A precise anamnesis collected by the emergency physician or the 
neurologist is critical in order to identify the precise moment of onset of the 
ischemic event. Important information comprises a detailed description of 
the episode, relevant clinical and pharmacological anamnesis plus 
significant risk factors. Clinical neurological assessment of the patient in 
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acute care is usually supported by the “National Institutes of Health Stroke 
Scale” (NIHSS), allowing a relatively impartial quantification of the severity 
of the neurological deficits caused by a cerebrovascular accident. The 
NIHSS is structured as a checklist and allows the clinician a rapid yet 
precise assessment of the acute stroke patient, including consciousness, 
visual, motor, sensory and language functions (Goldstein et al. 1989; 
Goldstein and Samsa 1997; Richardson et al. 2006; Meyer and Lyden 
2009). 
Because of the sophisticated and highly differentiated anatomy and 
physiology of the encephalon, the manifestations of a stroke cover a wide 
spectrum and differ widely according to the artery and the cerebral 
vascular territory involved in the apoplectic event. A stroke involving the 
anterior and middle cerebral artery territorium causes, among others, 
motor or sensory deficits of the contralateral bodyside with variable 
involvement of the extremities (primary motor cortex in the precentral 
gyrus, premotor cortex, supplementary motor cortex, centrum semiovale 
and internal capsule). In a flow disturbance in the internal carotid artery 
symptomatic from both anterior and media territorium can occur in addition 
to amaurosis fugax or transmonocular blindness. Involvement of the 
posterior cerebral artery territorium typically causes ipsilateral 
hemianopsia or cortical visual impairment (optic radiation and visual 
cortex) plus eventually contralateral motor and sensory deficits (posterior 
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limb of the internal capsule). Considering the complexity of the brain stem, 
where numerous nuclei and white matter tracts are precisely organized in 
a rather restricted space, a stroke affecting the mesencephalon, pons or 
medulla oblongata usually manifests with a complex and variable 
constellation of signs and symptoms including hemi- or tetraparesis, 
sensory impairment in all extremities, eye movement disorders and 
diplopia, vertigo, tinnitus, nausea, vomiting and consciousness 
impairment. In addition, a variable involvement of the cranial nerves (III – 
XII) can manifest. A cerebellar apoplectic event affects coordination and 
causes limb and gait ataxia. Along with these symptoms, dominance plays 
an important role since the dominant encephalic hemisphere also controls 
the language. The left cerebral hemisphere is dominant in virtually all right-
handed and ca. 60 % of left-handed individuals. An affection of a dominant 
left-brain hemisphere, in addition to the above cited ones, can cause 
impairment of different language functions, including aphasia (motor, 
sensory or mixed), apraxia, acalculia and agraphia. A stroke involving a 
nondominant hemisphere may cause neglect, dysarthria and ipsilateral 
gaze preference (Searls et al. 2012). A representation of the brain arterial 
vessels can be seen in figure 1. 
As mentioned above, about 90 % of patients suffering a stroke will present 
permanent sequelae, affecting their everyday life in various degrees. In 
order to assess and objectively quantify the impairment in common life 
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activities experienced by stroke patients the modified Ranking Scale 
(mRS) was originally introduced by Dr. Rankin in 1957 (Rankin 1957; 
Quinn et al. 2007; Quinn et al. 2008) and subsequently modified to its 
current form in the end of the 1980s (Farrell et al. 1991). The mRS 
classifies the disability in 7 degrees, spanning from 0 to 6 (No Symptoms 





Considering the acute nature and the necessity of rapid treatment, 
neuroimaging represents a cornerstone in the work-up of stroke,  
supplying crucial information to the diagnosis and management of 
patients, particularly involving therapy in acute setting (NINDS 1995). 
As of today, both magnetic resonance and computed tomography imaging 
can be used in stroke imaging. Both techniques offer the possibility to 
identify fully infarcted as well as ischemic brain parenchyma and most 
critically the capability of distinguishing between the two. The potential of 
detecting salvageable brain tissue is with state-of-the-art scanners almost 
equal in both techniques. Despite the radiation dose, imaging via CT is 
often preferred due to widespread availability of CT scanners and reduced 
scanning time. MRI is typically reserved for chronic cases or control 
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examinations in stroke patients although protocols, work-flows and 
standard operating procedures vary between different institutions 
(Vymazal et al. 2012). Clinical neurological and non-contrast CT data may 
not fully depict the extension or the gravity of a brain ischemia, particularly 
in the hyperacute phase (Dromerick and Reding 1995; Mohr et al. 1995; 
Fisher 1997). Therefore further imaging techniques are necessary to 
accurately evaluate possible acute stroke interventions (Mohr 1997), 
including a representation of the brain vasculature (CT-Angiography) or of 
the cerebral perfusion (CT-Perfusion), thus allowing to distinguish fully 
infarcted from ischemic and thus salvageable brain parenchyma. 
 
In the Department of Diagnostic and Interventional Neuroradiology of the 
University of Medicine Göttingen, imaging in acute stroke is performed via 
multi-detector computed tomography (MDCT/ MDCT-Angiography/ 
MDCT-Perfusion) or flat-detector computed tomography (FDCT/ FDCTA) 
(Leyhe et al. 2017; Psychogios et al. 2017) as explained in detail in 
Materials and methods, interventional treatment. An example of acute 
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2.2 Stroke treatment  
 
 
2.2.1 Overview and intravenous therapy 
 
Considering the burdening and often permanent consequences of an 
ischemic cerebrovascular event, adequate and prompt treatment is 
required on acute setting and is a key healthcare priority (Evans et al. 
2017), thus promoting research to establish an effective therapy. Current 
therapeutic options for acute stroke include thrombolysis, such as with 
intra-venous recombinant tissue-type plasminogen activator and 
interventional treatment. 
IV therapy for ischemic stroke with alteplase (trade names Activase and 
Actilyse) was first authorized by the US Food and Drug Administration in 
1996, led by the conclusions of the clinical trial of the National Institute of 
Neurological Disorders and Stroke (National Institute of Neurological 
Disorders and Stroke rt-PA Stroke Study Group 1995). IV therapy played 
a major role in the establishment of stroke management. Stroke services 
“flourished around” intravenous thrombolysis, with the creation of 
specialized stroke units, dedicated workflows and operating procedures 
plus highly trained personal, both inside and outside the hospitals. Several 
attempts have been made to raise awareness in general population in 
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order to recognize a possible stroke, react promptly and consequently be 
able to rapidly receive adequate therapy (Goldstein 2014; Romano and 
Sacco 2015). These have been effectively summarized in the rather 
catchy slogan “Time is brain” (Saver 2006). 
IV therapy with r-tPA is still performed to this day within max. 4.5 hours 
from begin of the symptomatic, achieving however a low recanalization of 
the occluded vessel (< 30 % of patients) (Bhatia et al. 2010; Wardlaw et 
al. 2012). This therapeutic approach has also demonstrated reduced 
effectiveness in the recanalization of large intracranial arteries occlusions 
(distal internal carotid and basilar artery), with a positive clinical outcome 
(mRS 0 -2) in  ca. 25 % of cases (Fischer et al. 2005; Rubiera et al. 2005). 
Relevant predictors of poor outcome with IV therapy are the length (Riedel 
et al. 2010; Riedel et al. 2011; Kamalian et al. 2013; Mishra et al. 2014) as 
well as the localization of the clot (Hirano et al. 2010; Saarinen et al. 2012). 
In particular patients with longer thrombi and/ or location in larger vessels 
(ICA, proximal MCA and BA) respond poorly to IV r-tPA. IV therapy 
presents further and well recognized limitations, including a limited time 
frame of administration (up to 4.5 hours) plus several contraindications 
due to the high bleeding risk (including coagulation disorders, bleeding 
diatheses, oral anticoagulation such as with sodium warfarin, recent 
bleeding, positive anamnesis for brain neoplasm or hemorrhage and 
surgery in the last 3 months among several others) (Jauch et al. 2013; 
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Berkhemer et al. 2015). This relative lack of effectiveness combined with 
the relevant limitations of application of the only approved therapy of the 
time contributed to the development of endovascular techniques for 
ischemic stroke.  
 
 
2.2.2 Endovascular treatment 
 
Intra-arterial stroke treatment comprises the pharmacological 
disaggregation of the clot via endovascularly applied thrombolytic drugs 
and the mechanical removal of the thrombus (Berkhemer et al. 2015). The 
first was introduced systematically during the late 1990s with an initial trial 
called PROACT: “Prolyse in Acute Cerebral Thromboembolism” (del 
Zoppo et al. 1998). 
IA thrombolytic treatment consists in direct injection of thrombolytic agents 
in close proximity to the thrombotic occlusion under x-ray guidance. 
Although early randomized trials and subsequent meta-analyses (Lee et 
al. 2010) demonstrated a potential benefit of intra-arterial treatment with 
prourokinase (del Zoppo et al. 1998; Furlan et al. 1999) or urokinase 
(Ogawa et al. 2007), IV therapy was not administered in the control groups 
of these studies, making the validity of these results doubtful (Berkhemer 
et al. 2015). Furthermore the conclusions of recently conducted trials  
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investigating intra-arterial therapy with thrombolytic drugs (such as the 
IMS III, SYNTHESIS Expansion and MR RESCUE) have contributed to 
the uncertainty of significance of this approach (Broderick et al. 2013; 
Ciccone et al. 2013; Kidwell et al. 2013). As a result thrombectomy has 
widely superseded IA thrombolytic drugs as interventional treatment of 




2.2.3 Mechanical thrombectomy 
 
The goal of mechanical thrombectomy is to restore perfusion in ischemic 
brain parenchyma by means of endovascular mechanical removal of the 
thrombus, hence avoiding or limiting infarction of the tissue (Przybylowski 
et al. 2014). This is made possible by a vast assortment of dedicated 
interventional materials, as represented in figure 3 (Raychev and Saver 
2012). The first endovascular device (Merci Retrival System, MERCI) was 
approved for clinical application by the FDA in August 2004 (Felten et al. 
2005). The MERCI and subsequent Multimeric trials demonstrated 
positive recanalization rates (60.8 and 69.5 % respectively) with good 
neurological outcome in 34 % of patients, using the Merci device plus 
thrombolytic therapy (IA/ IV) (Smith et al. 2005; Smith et al. 2008). These 
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encouraging results fostered the development of further techniques and 
materials, with the introduction of the Solitaire FR Revascularization 
Device and Trevo ProVue Retriever, so called “Stent-retrievers”. Their 
efficacy was put to test in 2012 in two different randomized trials, the 
SWIFT (Saver et al. 2012) and TREVO 2 (Nogueira et al. 2012). Both 
devices demonstrated a remarkably better recanalization compared with 
to MERCI. The Solitaire FR performance was as a matter of fact so 
remarkably superior to the MERCI (recanalization rate: 83 % vs 48.1 %, 
mortality rate at 3 months: 17.2 % vs 38.2 %), that the SWIFT trial was 
interrupted earlier than planned (Saver et al. 2012). 
During the first half of the 2010 decade several new generation stent 
retrievers were tested. The results of nine randomized controlled trials 
were all issued in a rather short interval, representing a true milestone in 
interventional stroke treatment (Berkhemer et al. 2015; Campbell et al. 
2015; Goyal et al. 2015; Jovin et al. 2015; Saver et al. 2015; Bracard et al. 
2016; Mocco et al. 2016; Khoury et al. 2017a; Khoury et al. 2017b; Muir et 
al. 2017). The first published study has been the “Multicenter Randomized 
Clinical Trial of Endovascular Treatment for Acute Ischaemic Stroke” in 
the Netherlands. The so called “MR CLEAN” study demonstrated the clear 
superiority of thrombectomy vs. standard medical treatment as therapy of 
acute stroke with LVO in the anterior cerebral circulation (ICA/ MCA), 
improving functional independence at 90 days (evaluated with the mRS). 
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All the following, above cited studies confirmed the MR CLEAN results and 
were stopped earlier than planned because of manifest efficacy and/ or 
loss of principle of equipoise (Evans et al. 2017). The HERMES meta-
analysis of the first five published studies („Highly Effective Reperfusion 
Evaluated in Multiple Endovascular Stroke Trials“) was subsequently 
conducted and published in 2016 (Goyal et al. 2016). HERMES provided 
a significant amount of data, most importantly indicating that stroke 
patients treated with thrombectomy are more likely to achieve functional 
independence at 90 days (i. e. mRS 0–2, no symptoms to slight disability) 
in comparison with patients who received best medical treatment (46.0 % 
versus 26.5 %). IV r-tPA was administered to 83 % of patients in the 
thrombectomy population and 87 % of those in the control population. 
Remarkably no significant difference was observed between the two 
groups regarding mortality at 90 days or the risk of subarachnoid or 
intracerebral hemorrhage (Evans et al. 2017). Successive meta-analyses 
confirmed the results of the HERMES study (Bush et al. 2016; Rodrigues 
et al. 2016). The convincing evidence of these trials led to an update of 
stroke practice guidelines in North America (Powers et al. 2015; Casaubon 
et al. 2016; Powers et al. 2018) and in Europe as well (Wahlgren et al. 
2016; White et al. 2017). The new recommendations indicate that 
thrombectomy should be performed in patients older than 18 years old with 
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an occlusion of the ICA or proximal MCA (M1 segment) within 6 hours of 
symptom onset (Powers et al. 2018). 
A further meta-analysis of the five studies (Saver et al. 2016) 
demonstrated improved clinical outcome even with embolectomy carried 
out up to 7.3 hours after onset. In 2018 two further important randomized 
trials were published: DAWN and DEFUSE 3. These studies reported 
better outcomes for disability at 90 days with thrombectomy plus standard 
care compared to standard care alone in selected group of patients treated 
up to 24 and 16 hours after ischemic stroke onset respectively (Albers et 
al. 2018; Nogueira et al. 2018), although the greatest benefit can be 
achieved with recanalization within 2 hours after onset. Just as for IV r-
tPA, rapid patient management and interventional treatment are key to 
achieving the best possible outcomes. Indeed the time factor (particularly 
from  onset of symptoms to admission in the hospital and to recanalization) 
plays a major role in the probability in attaining a favorable neurological 
outcome after thrombectomy (Saver et al. 2016). As for intravenous 
therapy, efficient patient management and rapid interventional treatment 
are critical for the treatment success, since an extended interventional 
time above 60 minutes is linked with lower reperfusion percentage and an 
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2.2.4 Devices and technique 
 
In the last 15 years interventional neuroradiology witnessed a remarkable 
expansion of devices and techniques in order to achieve the primary goal 
of rapid and safe recanalization of large vessel occlusion and 
consequently restore the reperfusion of the brain.  
Following the encouraging results of the randomized trials (Berkhemer et 
al. 2015; Campbell et al. 2015; Goyal et al. 2015; Jovin et al. 2015; Saver 
et al. 2015; Bracard et al. 2016; Mocco et al. 2016; Khoury et al. 2017a; 
Khoury et al. 2017b; Muir et al. 2017), the stent retriever became a 
frequently used device for mechanical thrombectomy (figure 4). Besides 
the main retrieving tool, numerous support equipment is available to the 
neurointerventionalist, including but not limited to balloon guide catheters, 
aspiration catheters and vacuum devices. Additionally, the different 
etiology/pathophysiology of the LVO (e. g. free-floating thrombus, single 
vs. tandem lesion, concurring arterial dissection), the thrombus type and 
anatomic variability of the patient may challenge the standard approach 
and require different techniques and materials (Evans et al. 2017).  
During a standard procedure, after puncture of the common femoral artery 
under local anesthesia, a large (typically 8 French) guiding catheter is 
steered under x-ray guidance to the ICA ipsilateral to the occlusion. 
Through the guide catheter an intermediate catheter (commonly 5 or 6 Fr) 
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is positioned within the cerebral arterial circle, often in the distal segments 
of the ICA. A microcatheter (usually 0.018 inches) is then pushed past the 
thrombus under aspiration or with the assistance of a microguidewire 
(Maus et al. 2017; Maus et al. 2018). After reaching a satisfying set up, 
the microguidewire is carefully extracted and the stent retriever is 
deployed, unfolding around the clot, similarly to a stent, but unlike this one 
remaining attached to its wire. After a variable time, but usually 2-3 
minutes, the stent retriever gets enmeshed with the thrombus. At this point 
the stent retriever gets retracted in the intermediate catheter under 
vacuum aspiration. The stent retriever- intermediate catheter system is 
then removed through the guide catheter and angiography series are 
performed in standard technique to assess the reperfusion of the brain 
territory (Evans et al. 2017; Maus et al. 2017; Maus et al. 2018). A 
summary of the main steps of a mechanical thrombectomy procedure can 
be found in figure 5, while figure 6 pictures a thrombus extracted with a 
stent retriever.  As stated above, vessel conformation, the mechanism of 
the LVO, thrombus type and location might require a diverse approach as 
well as different techniques and materials. 
The issue of anesthesia versus awake thrombectomy is still somewhat 
controversial. In two recent prospective, randomized studies  (GOLIATH, 
General or Local Anesthesia in Intra-Arterial Therapy and ANSTROKE, 
Anesthesia During Stroke) no difference in terms of neurological outcome 
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where found when comparing general anesthesia to conscious sedation 
(Löwhagen Hendén et al. 2017; Simonsen et al. 2018). Our current 
approach (further discussed in materials and methods, interventional 
treatment) is to conduct endovascular treatment under conscious sedation 
with support from an anaesthesiologist. General anesthesia is only applied 
in cases of lack of consciousness to protect the airways or in the event of 
agitation of the patient, which might complicate the procedure or 




2.3 Revascularization scores 
 
To categorize and standardize the success of the interventional treatment 
several grading systems have been used. All different grading systems 
classify the results of endovascular therapy based on the amount of 
revascularization of previously ischemic brain tissue (Zaidat et al. 2012). 
Historically the very first score utilized to assess cerebral reperfusion has 
been the “Thrombolysis in Myocardial infarction” (TIMI) scale, originally 
constructed to quantify the reperfusion of the myocardium after 
percutaneous coronary angioplasty (TIMI Study Group 1985; Gobin et al. 
2004). A modified version of TIMI scale, named “Thrombolysis in Cerebral 
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Infarction” (TICI) grading, was introduced in 2003 by Higashida and 
colleagues and represented the first dedicated scale for cerebral 
reperfusion (see table 2) (Higashida et al. 2003). Further several scales 
have been described, such as the AOL and the ACG (IMS II 2007; Bang 
et al. 2011). Currently the most utilized in clinical practice is the “Modified 
Treatment in Cerebral Infarction” score (mTICI), shown in table 3 (Zaidat 
et al. 2013). In 2014 Almekhlafi and colleagues proposed an additional 
category to the mTICI scale, named mTICI2c (indicating a “near complete 
reperfusion except slow flow or few distal cortical emboli”), see table 4. In 
their study they showed that mTICI2c reperfusions result in significantly 
better early neurological improvement compared to mTICI2b (Almekhlafi 
et al. 2014). These results were also validated by Tung and colleagues in 
2017 (Tung et al. 2017). Recently Liebeskind and colleagues reexamined 
the data from the HERMES study utilizing a new 7-point eTICI score 
(Expanded Treatment in Cerebral Infarction) in relation to the prediction of 
functional outcome at 90 days. Their results indicated that increasing TICI 
grades were linked with better clinical outcomes (Liebeskind et al. 2019). 
As techniques and expertise in interventional stroke therapy evolve and 
improve, so do the radiological and clinical outcomes. Most of the actual 
interventional outcomes are placed somewhere between 50 to 99 % of 
anterograde revascularization of the previously ischemic territory 
(Almekhlafi et al. 2014). Parallel to these developments there has been a 
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significant change in the definition of what should be considered a 
successful recanalization result, increasing the threshold from TICI 2a to 
TICI 2b (Jayaraman et al. 2013).  
Although the mTICI represents a practical and relatively simple scale 
easily utilized in everyday clinical practice, it shows a considerable lack of 
predictability of clinical outcome in middle to high percentages of 
revascularization of ischemic territory (50 to 99 % of territory are graded 
all together TICI 2b, see table 3).  This wide spectrum of radiological 
results correlates therefore with an equally heterogeneous variety of 
clinical outcomes. In all likelihood a difference in almost 50 % of 
reperfused brain territory can have a marked impact on the neurological 
outcome of the patient. To imagine a scenario, the ICA supplies through 
the ACA and MCA ca. 72 % of the ipsilateral cerebral hemisphere 
(Zarrinkoob et al. 2015). In a distal ICA occlusion therefore up to 72 % of 
a brain hemisphere volume can become ischemic due to the thrombus, 
depending on the rate of collateralization. A successful revascularization 
with mTICI2b (50 – 99 %) could then mean a loss of 1 to 36 % of the 
volume of the cerebral hemisphere. It is intuitive to understand that the 
neurological outcome may vary considerably within this range (also being 
dependent on the localization of the infarction), yet the revascularization 
result would still be classified as mTICI2b. 
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So ultimately one of the major issues of mTICI scale is that mTICI2b is a 
very broad definition and de facto a rather imprecise grade covering 50-
99 % of reperfused territory, lacking adequate predictability of clinical 
outcome (Kallmes et al. 2018). Even the newly introduced mTICI2c 
category does not solve this issue of the mTICI scale and has also shown 
unsatisfying inter-reader agreement, likely because of vague criteria (Tung 
et al. 2017). Numerous authors reported further limitations of the TICI 
scale, including internal inconsistencies (Kallmes 2012), confusing 
nomenclature (Tomsick 2007) and a substantial variability in the definition 
and application of the TICI scale in the literature (Fugate et al. 2013). 
Despite the relative diffusion of the mTICI scale, the current heterogeneity 
in brain angiographic revascularization scores represents a relevant 
hindrance to the development in interventional treatment, not to mention 
the possible discrepancies in everyday clinical practice. Furthermore, the 
varied definitions within a certain scale plus a certain inaccuracy, and this 
holds true particularly for the mTICI score, might cause confusion to its 
application and interpretation, potentially affecting its predictive power 
regarding clinical outcome. Ideally an optimal grading system should 
demonstrate a good correlation with the clinical neurological outcome, 
simplicity and feasibility in the clinical practice and high inter-rater 
reproducibility (Zaidat et al. 2013). To date no revascularization score 
takes the effect of time into account, which probably represents a major 
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disadvantage. In a case with a particularly challenging and protracted 
intervention, successful angiographic recanalization might be achieved, 
yet a considerable amount of brain parenchyma may have meanwhile 
infarcted and poor neurological status would likely follow, thus likely 
resulting in a discrepancy between angiographic and clinical outcome. 
 
 
2.4 Study design 
 
In order to address these limitations we evaluate the novel angiographic 
revascularization grading, named “Expanded Treatment in Cerebral 
Infarction” (eTICI) in a real world cohort. The eTICI score is partially based 
and could be considered an expansion on the mTICI score (see table 5 
and 6). The eTICI score classifies the revascularization outcome in 7 
grades (from 0 to 3). Grades 0 – 2a are equivalent to the similar grades 
on the mTICI scale. Angiographic revascularization outcomes with 50 to 
99 % of anterograde revascularization of the previously ischemic territory, 
which are graded altogether grade 2b in the mTICI score, are divided in 3 
grades in the eTICI score (in detail grade 2b50, 2b67 and 2c. The definition 
of eTICI2c differs from mTICI2c. See table 4, 5 and 6). Grade 3 defines 
complete reperfusion in the eTICI as well as in the mTICI scale.  
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In this study we examine the ability of the newly introduced expanded TICI 
(eTICI) compared to the modified TICI (mTICI) angiographic 
revascularization grading in predicting the favorable clinical neurological 
outcome and functional independence (Farrell et al. 1991) in patients with 
LVO after treatment with endovascular thrombectomy.  Additionally, since 
time heavily affects the neurological outcome in acute ischemic stroke, the 
influence of the “time factor” on the angiographic results (also assessed 
with the eTICI scale) will be investigated. 
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3 MATERIALS AND METHODS 
 
 
3.1 Study population 
 
The prospectively acquired database of the Department of Neuroradiology 
of the University of Medicine, Göttingen was retrospectively queried for all 
stroke patients who received interventional therapy for LVO between 
January 2015 and April 2017. LVO involving both the anterior (distal ICA, 
MCA) and posterior circulation (BA, PCA) were included in the study. We 
also enclosed cases which presented with concomitant cervical ICA 
affection (tandem lesions, including both subocclusive stenosis and 
occlusion) as well as occlusion exclusively of the proximal M2-segment of 
the MCA. No other in- or exclusion criteria were applied, resulting in a 
cohort of 225 patients. 
After the evaluation of angiograms with the eTICI score was performed 
(see 2.3 Radiological assessment), the patient cohort was screened for 
cases who underwent endovascular treatment of LVO in the anterior 
circulation and received successful recanalization (eTICI2b50 – eTICI3), 
which resulted in a second study population of 164 individuals. 
All analyzed intra-arterial thrombectomies were performed prior to the 
01.08.2017. The patient`s informed consent for medical treatment was 
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acquired in line with the institutional guidelines of the UMG. Ethics 
committee vote for the study was obtained (Application number 16/2/16, 
13/7/15An and 7/5/19). No individual-related data has been included in 
the study. No further questions regarding medical data or any data 
whatsoever were directed to the patients, their relatives or other hospitals. 
 
 
3.2 Interventional treatment 
 
Endovascular therapy was considered suitable for patients within 6 hours 
of onset of symptoms presenting with a large vessel occlusion and 
absence of an intracranial bleed. Imaging was performed by either multi-
detector (MDCT/MDCT-Angiography. SOMATOM Definition AS 128-
slices, Siemens Healthcare, Germany) or flat-detector computed 
tomography (FDCT/FDCTA. AXIOM Artis biplane, Siemens Healthcare) 
(Leyhe et al. 2017; Psychogios et al. 2017). Within the first 6 hours of 
symptom onset patients received EVT independently to the ASPECTS 
(Alberta Stroke Program Early CT Score) (Barber et al. 2000; Pexman et 
al. 2001). After 6 hours from onset of symptoms supplementary imaging 
via computed tomography perfusion (CTP) was conducted and exclusively 
cases with a CBV-CTP ASPECT (cerebral blood volume in CTP) score of 
5 or more were considered eligible for EVT. Ancillary IV therapy with r-tPA 
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was delivered in conformity with the present German guidelines (DGN 
2016). Intra-arterial r-tPA has never been administered in cases included 
in the study. 
Patients transferred to the department of neuroradiology of the UMG from 
an external stroke center and potentially treatable with EVT, received 
imaging (MDCT/MDCTA or FDCT/FDCTA) before treatment to exclude an 
intracranial bleed and to assess the cerebral vascular status. All 
mechanical thrombectomies were performed in the neuroangiography 
suite of the Department of Diagnostic and Interventional Neuroradiology 
of the University of Medicine, Göttingen, equipped with an AXIOM Artis 
biplane angiographic imaging system (Siemens Healthcare). Most 
patients received EVT under conscious sedation while general anesthesia 
with intubation was necessary when psychomotor agitation or impairment 
of consciousness were present. 
Mechanical thrombectomy was performed in the majority of cases using a 
standard tri-axial approach with either an 8F femoral long sheath 
(Destination Terumo Medical, Somerset, NJ, USA) or an 8F guiding 
catheter (VISTA Brite tip, Cordis, Milpitas, CA, USA ), a 5 or 6F 
intermediate/aspiration catheter (Catalyst, Stryker Neurovascular, 
Kalamazoo, MI, USA or Penumbra ACE 64/68, Penumbra, Alameida, CA, 
USA), a microcatheter (Trevo pro 14/18, Stryker) and a stent-retriever 
(Trevo pro Vue 4x30mm, Stryker Neurovascular). Different thrombectomy 
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techniques were performed comprising “a direct aspiration first pass 
technique” (ADAPT) (Turk et al. 2014), Solumbra (Behme et al. 2016) and 
stent assisted vacuum locked extraction (SAVE) (Kowoll et al. 2016; Maus 
et al. 2017). From July 2015 on all patients were treated using solely SAVE 
(Maus et al. 2017; Maus et al. 2018). See figure 5 for a detailed illustration 
of the SAVE technique. A balloon guide catheter was never utilized in the 
cases included in the study. The total of passes performed (i. e. 
thrombectomy maneuvers) was judged singularly in every case by the 
interventional neuroradiologist.  
 
 
3.3 Radiological assessment 
 
The angiographic imaging was retrospectively and independently 
examined by two readers with varied experience in interventional 
neuroradiology (I. Tsogkas > 5 years and R. Colla > 3 years), who were 
blinded to all clinical data. The amount of reperfusion of the ischemic 
territory was assessed in percentage analyzing postero-anterior as well as 
lateral view images of the final angiograms after EVT, based on the 
definitions of the eTICI scale. Regarding large vessel occlusions involving 
the posterior circulation, the quantification was similarly adapted to the 
correspondent supplying brain area and judged accordingly in every single 
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case. All images have been classified via mTICI score immediately after 
EVT and before further data was included into the data-base; both readers 
were blinded to these data as well. In cases with score disagreement the 
angiograms were reexamined by the same two readers in a collective 
meeting in order to attain a general agreement, therefore generating an 
additional harmonized body of data. This was then used for further 
analysis. The initial separate evaluation of the two readers was kept for 
calculation of the interclass correlation coefficient.  
The 7-point scale eTICI is structured as follows:  eTICI0 = 0 % = mTICI0; 
eTICI 1 = reduced clot without any reperfusion = mTICI1; eTICI2a = 1-49 
% = mTICI2a; eTICI2b50 = 50-66 % = mTICI2b; eTICI2b67 = 67-89 % = 
mTICI2b; eTICI2c = 90-99 % = mTICI2b; eTICI3 = complete reperfusion = 
mTICI3 (see table 5 and 6). An example of an ICA/MCA reperfusion 
grading from eTICI2a to eTICI2c (with mTICI2b divided into eTICI2b50, -
2b67 and -2c) is given in figures 7-10.  
 
 
3.4 Clinical assessment 
 
The ischemic stroke database of the Department of Neuroradiology of the 
UMG was interrogated for the following information: age, gender, time of 
symptom onset/ wake up, site of occlusion, baseline NIHSS, baseline 
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mRS, discharge NIHSS, discharge mRS, 90 days mRS, all intra hospital 
time points: admission, CT, tPA start, groin puncture, reperfusion and final 
angiogram. All neurological assessment data were collected and entered 
in the stroke database by an experienced vascular neurologist (I. Maier > 
5 years or J. Liman > 10 years). Data at 90 days after ischemic stroke and 
EVT was acquired during a follow up examination of the patients by the 
same vascular neurologists. The two examining neurologists were blinded 
neither to the angiographic result of the interventional procedure nor to the 
precedent clinical data. Functional independence was designated as a 90-
day mRS score of 0 to 2. 
 
 
3.5 Statistical analysis 
 
Statistical analysis was conducted with either SAS 9.4 (SAS, Wallisellen, 
CH) or Med Calc software (Med Calc, Ostend, Belgium). At the beginning 
of the analysis relevant population characteristics were examined. An 
overview of the results of that investigation can be found in table 7 and 
10. Analysis comparing eTICI with mTICI were conducted exclusively on 
cases of LVO in the anterior circulation (ICA and MCA). Regarding the 
comparison of mTICI2b with its eTICI equivalents (eTICI2b50, -2b67 and 
-2c) results of all patients were included in the examination. Receiver 
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Operating Characteristics (ROC) curves of eTICI and mTICI were obtained 
comparing good clinical outcome (mRS 0-2 at 90 days) versus unfavorable 
outcome (mRS 3-6 at 90 days) as dichotomized classification variables. 
The difference between the two ROC-curves (eTICI and mTICI) was then 
additionally tested applying the DeLong test comparing the area under the 
curves (AUC) (DeLong et al. 1988).  
To assess if the subdivision of mTICI2b category into corresponding 
eTICI2b50, -2b67 and -2c subtypes could provide more precise prediction 
of clinical outcome, these two groups were tested concerning the 
difference in outcome (favorable: mRS 0 – 2 and unfavorable: mRS 3 – 6) 
with the Jonckheere-Terpstra test (Bewick et al. 2004). The Bonferroni 
correction for the p-value was added to control for the family-wise error 
rate (Ranstam 2016). Inter-rater agreement between neuroimaging 
readers was calculated with Cohen’s Kappa (Cohen 1960) and interclass 
correlation coefficient (ICC) (Donner et al. 1998). 
Concerning the analysis of the time factor, the clinical outcome at 90 days 
has been dichotomized in two categories (favorable outcome: mRS 0 – 2 
and unfavorable outcome: mRS 3 – 6). The following time parameters 
were analyzed (admission to recanalization and groin puncture to 
recanalization) together with successful revascularization scores 
(eTICI2b50 to eTICI3) in the multiple logistic regression analysis 
(Sperandei 2014). In each of the two models p-values for eTICI grade, the 
 
 - 34 - 
time frames and the patient’s age were calculated. The influence of time 
on the angiographic results (assessed with the eTICI scale) and on the 
treatment outcome (good vs. poor outcome) was investigated using 
specific intercepts in the models. These models assume that the effect of 
time is constant for the scores of the eTICI scale (eTICI2b50 – 3) over 
time. 
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4 RESULTS 
 
4.1 Large vessel occlusion 
 
Collectively 225 patients were enclosed in the study. The median age was 
76 (Interquartile range: 66-82) years, the NIHSS score at baseline was 16 
(IQR: 10-20); 48.4 % were male and 51.6 % were female patients. The 
most common localization of LVO was the MCA (132/225, 58.7 %) 
followed by the ICA (64/225, 28.4 %); in 44 cases (44/225, 19.6 %) a 
tandem occlusion was present, simultaneously involving the ICA and the 
MCA. In a minority of cases the posterior circulation was affected: in 24 
cases a BA occlusion (24/225, 10.7 %) and in 5 cases a PCA occlusion 
(5/225, 2.2 %) was treated (see table 7 and figure 11). 
 
 
4.2 Reperfusion and clinical outcomes 
 
The median time from arterial puncture to reperfusion was 50 min (IQR: 
32-74). The degree of recanalization covered the whole range of the 7 
points eTICI, varying from no reperfusion (eTICI0) to complete reperfusion 
of the previously ischemic territory (eTICI3). All angiographic views were 
adequate to the assessment of the results after mechanical 
 
 - 36 - 
thrombectomy, so the grade of reperfusion could be evaluated in all the 
cases included in the study, resulting in 225 eTICI scores.  Recanalization 
could not be achieved in 13 cases (13/225, 5.2 %), accounting for 9 cases 
of eTICI0 (9/255, 4 %) and 4 cases of eTICI1 (4/255, 1.8 %). In another 
22 cases (22/225, 9,8 %) an eTICI2a result was obtained. In the remaining 
84.4% of cases substantial perfusion was restored with eTICI2b50 
(23/225, 10.2 %), eTICI2b67 (71/225 31.6 %), eTICI2c (46/225, 20.4 %) 
and eTICI3, i. e. complete reperfusion (50/225, 22.2 %), see table 7 and 
figure 12. A favorable clinical outcome (mRS 0-2 at 90days) was achieved 
in 88 cases (88/225, 39.1 %), see table 7 and figure 13. Clinical 
demographics, angiographic and procedural information of patients are 
summarized in table 7.  
Higher eTICI reperfusion grades are linked with better clinical outcomes 
(mRS at 90 days), particularly the higher the eTICI score is (i. e. greater 
reperfusion), the lower the mRS at 90 days tends to be (i. e. better 
neurological outcome). A higher revascularization score is related to a 
greater likelihood of achieving a good neurological outcome at 90 days 
(eTICI0: 0 %, eTICI1: 0 %, eTICI2a: 18 %, eTICI2b50: 17,39 %, 
eTICI2b67: 23,94 %, eTICI2c: 54,34 %, eTICI3: 76 %). A relatively wide 
distribution of neurological outcomes at 90 days stratified along all eTICI 
scores can nevertheless be observed, see table 8 and figure 14. 
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Concerning the analysis comparing eTICI scores with mTICI scores, ROC 
analysis with dichotomized mRS scores at 90 days (mRS 0-2) as outcome 
were calculated using the respective scores. Derived from the ROC-curve 
the AUC could be calculated leading to an AUC of 0.779 (95 % CI: 0.719-
0.839) for eTICI and 0.740 (95 % CI: 0.683-0.797) for mTICI. Using the 
Youden-Index as criterion for optimal cutoff values, optimal cutoff for eTICI 
was achieved at eTICI2b67 with 75.9 % sensitivity (95 % CI: 67.86 % -
82.8 %) and a 71.6 % specificity (95 % CI: 60.98 % - 80.7 %) for favorable 
outcome. For mTICI a cutoff at mTICI2b with 89.7 % sensitivity (95 % CI: 
83.44 % - 94.3 %) and 44.3 % specificity (95 % CI: 33.72 % - 55.3 %) was 
obtained (figure 15). Comparing AUC of both raters resulted in a p-value 
of 0.047. 
Analyzing outcome differences of eTICI2b50, -2b67 and -2c scores in 
cases which were initially categorized as mTICI2b resulted in a significant 
association between increasing scores and growing probability of success 
(p=0.033). In the study cohort mTICI2b patients had a probability of 36 % 
for a favorable outcome, whereas the granulated success probabilities 
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4.3 Interrater reliability 
 
Overall agreement (Cohen’s Kappa) between raters was 0.706 (95 % CI: 
0.645-0.769). Interclass correlation (ICC) within eTICI was 0.862 (95 % 
CI: 0.821-0.894).  
 
 
4.4 Role of time 
 
The screening of the initial patient cohort for cases of LVO in the anterior 
circulation who received EVT with successful recanalization (eTICI2b50 – 
eTICI3) produced a second study population of 164 patients.  45.1 % of 
these were male and the median age was 76 (IQR 66 – 82). The LVO 
involved the distal ICA in 31 % (51/164) and MCA in the remaining 69 % 
(113/164) of cases.  
Median procedural times included the following results: admission to 
recanalization time: 97 minutes (IQR 76 – 116 min), admission to groin 
puncture: 47 min (IQR 29 – 63), groin puncture to recanalization: 47 min 
(IQR 31 – 66). Angiographic outcomes: 12.2 % (20/164) of cases obtained 
an eTICI2b50 result, 36.6 % (60/164) eTICI2b67, 23.2 % (38/164) eTICI2c 
and 28 % (46/164) eTICI3.  The global of favorable outcome (mRS 0 – 2) 
was 42.7 % (70/164), subdivided in 15 % (3/20) for eTICI2b50, 18.3 % for 
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eTICI2b67 (11/60), 57.9 % (22/38) for TICI2c and 73.9 % (34/46) for 
eTICI3 (see table 10). 
In the analysis of time of admission to vessel recanalization the p-values 
resulted overall in p=0.2281 (OR 0.994, CI: 0.984-1.004) and p=0.0161 
(OR: 0.957, CI: 0.923-0.992) for patient’s age. Concerning the 
investigation inside the eTICI scale, double grade correlation p-values 
were: p=0.5744 (eTICI2b50 vs. 2b67), p=0.0388 (eTICI2b50 vs. 2c), 
p=0.0012 (eTICI2b50 vs. 3), p=0.0366 (2b67 vs. 2c), p<0.0001 (2b67 vs. 
3) and p=0.0731 (eTICI2c vs. 3). The odds change was calculated to be 
0.9939 per minute and 0.9574 per year of age. For a complete report of p-
values plus odd ratios of admission to recanalization see table 11 – 12 
and figure 16. 
In the evaluation of time of groin puncture to recanalization these p-values 
were calculated: for eTICI grades p<0.0001, overall p=0.1713 (OR 0.989, 
CI: 0.974-1.005) and for the age of the patient p=0.0139 (OR: 0.955, CI: 
0.921-0.991). About the comparison within the eTICI scale, the following 
double grade correlation p-values emerged: p=0.5017 (eTICI2b50 vs. 
2b67), p=0.0392 (eTICI2b50 vs. 2c), p=0.0016 (eTICI2b50 vs. 3), 
p<0.0001 (2b67 vs. 2c plus 2b67 vs. 3) and p=0.0933 (eTICI2c vs. 3). The 
odds change per minute was 0.9879 per minute and per year of age 
0.9550. The exhaustive report of p-values, odd ratios and confidence 
 
 - 40 - 
intervals of time from groin puncture to recanalization can be found in 
table 13 - 14 and figure 17. 
The regression analysis permits a computation of the probability or 
reaching a certain outcome, in this case: log odds (probability of good 
outcome (mRS 0 – 2) / probability of poor outcome (mRS 3 – 6). In the 
model of the groin puncture to recanalization the likelihood of good 
outcome could be calculated as follows: 
 𝐥𝐨𝐠 𝐨𝐝𝐝𝐬 = 5.3988 − (0.0108 𝑥 𝑔𝑟𝑜𝑖𝑛 𝑡𝑜 𝑟𝑒𝑐𝑎𝑛. 𝑡𝑖𝑚𝑒 [𝑚𝑖𝑛] ) − (0.0456 𝑥 𝑎𝑔𝑒 [𝑦𝑒𝑎𝑟𝑠]) −   
 : correction factor of the eTICI scale 
• eTICI3:  0.  
• eTICI2c:  0.9434. 
• eTICI2b67:  3.1095. 
• eTICI2b50: 2.5662. 
 
E. g. an 80 y. o. patient recanalized in 50 minutes (groin to recanalization) 
with an eTICI2c result would have a log odds for obtaining a good 
neurological outcome of: 
log 𝑜𝑑𝑑𝑠 = 5.3988 − (0.0108 𝑥 50) − (0.0456 𝑥 80) −   
log 𝑜𝑑𝑑𝑠 = 5.3988 − 0.54 − 3.648 − 0.9434 
log 𝑜𝑑𝑑𝑠 = 0.2674 
   The odds are: 1.31 and probability is: 0.57 
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In another example an 87 y. o. patient recanalized in 90 min. (groin to 
recanalization) with a eTICI2b50 result would have a log odds for 
achieving a good outcome of: 
log 𝑜𝑑𝑑𝑠 = 5.3988 − (0.0108 𝑥 90) − (0.0456 𝑥 87) −   
log 𝑜𝑑𝑑𝑠 = 5.3988 − 0.972 − 3.9672 − 2.5662 
log 𝑜𝑑𝑑𝑠 = −2.1066 
   The odds are: 0.122 and probability is: 0.11  
    
In a further example a 65 y. o. patient recanalized in 35 min. (groin to 
recanalization) with an eTICI3 result would have a log odds for obtaining 
a good outcome of: 
log 𝑜𝑑𝑑𝑠 = 5.3988 − (0.0108 𝑥 35) − (0.0456 𝑥 65) −   
log 𝑜𝑑𝑑𝑠 = 5.3988 − 0.378 − 2.964 − 0 
log 𝑜𝑑𝑑𝑠 = 2.0568 
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5 DISCUSSION 
 
This is the first study which investigates the 7-point expanded 
Thrombolysis in Cerebral Ischemia score (eTICI) in a real world study 
population. The research group of Liebeskind and collegues 
retrospectively analyzed the HERMES angiography dataset using the 
eTICI score in their recent publication (Liebeskind et al. 2019). This 
analysis confirms the higher incidence of occlusions of the MCA, followed 
by the ICA and then the posterior circulation in ischemic stroke. A higher 
reperfusion score is linked to a greater probability of achieving a favorable 
neurological outcome at 90 days. The results of this study show overall 
several advantages of the expansion of the widely used and accepted 
mTICI and the application of the eTICI score. In the first instance the eTICI 
leads to a better overall outcome prediction as validated by ROC analysis. 
Secondly outcome stratification of eTICI2b50, 2b67 and 2c compared to 
mTICI2b resulted in more accurate prediction of good outcome at 90 days 
(mRS 0-2). In our cohort a significant increasing trend was observed 
between eTICI2b50 to eTICI2c results and the probability of good outcome 
with higher eTICI scores underlines the value of a more precise 
interpretation of angiographic result after mechanical thrombectomy. The 
results of this study confirm most of the conclusions of Liebeskind and 
colleagues when analyzing the HERMES data with the eTICI score. In 
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contrast to their findings, a statistically significant difference between 
eTICI2b50 and eTICI2b67 concerning the prediction of functional outcome 
at 90 days could not be determined. An increasing trend towards better 
neurological outcome in the eTICI2b67 versus the eTICI2b50 could 
nevertheless be found (23,94 % and 17,39 % respectively). This 
phenomenon could partially be due to the different number of patients in 
the cohort of the two studies (HERMES: 801 subjects, eTICI2b50 103 
patients, eTICI2b67 218 patients. Present study: 225 subjects, eTICI2b50 
23 patients, eTICI2b67 71 patients) (Liebeskind et al. 2019). Moreover the 
angiographic results after mechanical thrombectomy were substantially 
better in comparison to the ones of the HERMES study (In HERMES 
eTICI2b50-eTICI3: 75,4 % versus 84,4 % in the present study) (Liebeskind 
et al. 2019). This phenomenon might be a manifestation of the improving 
trend in mechanical thrombectomy over the past years, concerning both 
interventional techniques and speed of reperfusion. This hypothesis is 
corroborated by the recent results of Psychogios et al. and Maus et al. 
(Psychogios et al. 2017; Maus et al. 2018).  
Furthermore, the eTICI score expands and implements the concepts 
proposed by Almekhlafi et al. and more recently by Tung et al. Both 
research groups suggested to add a supplementary category to the mTICI 
scale which indicates an almost complete reperfusion of the previously 
ischemic territory” named mTICI2c (Almekhlafi et al. 2014; Tung et al. 
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2017). Almekhlafi and colleagues showed that mTICI2c resulted in better 
clinical outcomes when compared to mTICI2b reperfusion. Tung’s 
research group also found significant differences between early and 90 
days neurological outcome when comparing patients with mTICI2c with 
patients having mTICI2b results. Remarkably, this was not observed when 
comparing mTICI3 with mTICI2c results (Tung et al. 2017). However, a 
noteworthy limitation of mTICI2c category is its somewhat unclear 
definition, being originally denominated as “near complete reperfusion 
except slow flow or few distal cortical emboli” (table 4). The eTICI scale 
overcomes this lack of precision by offering a clear percentage cutoff 
division to evaluate the grade of reperfusion for all its grades from 1 to 100 
%, hence including the eTICI2c (90-99 % of the territory. See table 5 and 
6).  
Determining clear percentage-cutoffs of the reperfused territory may not 
be easy in some cases and it might be influenced by the quality of the 
angiograms, but as shown in this study a distinction between three 
different mTICI2b grades (eTICI2b50 – 2c, 50-99 % of the previously 
ischemic territory) seems to be attainable in the everyday clinical setting. 
The initiating motive of the improvement of the angiographic scale in the 
above cited studies is the need to establish a more precise grading (see 
introduction, revascularization scores). A score which defines a “good” 
reperfusion result as an extremely broad area spanning from 51 to 99 %, 
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like mTICI2b does, is intrinsically weak in the predictive power of clinical 
outcome. More specifically in the current analysis 36 % of patients 
presenting with a mTICI2b result achieved a favorable neurological 
outcome at 90 days. When the mTICI2b category was granulated into 
three eTICI subgroups, a clear distinction of probability of outcome arose. 
In detail, 54 % of cases with an eTICI2c score reached a favorable 
neurological outcome at 90 days, while just ca. 17 % and 24 % of patients 
obtained a good outcome with an eTICI2b50 and eTICI2b67 result 
respectively (see table 9).   
Recently Kaesmacher et al. reported a significant difference in the rate of 
good neurological outcome comparing mTICI2b and mTICI2c/3 results, 
specifically 28.7 % vs. 46.5 % (p=0.008) (Kaesmacher et al. 2018). This 
research group also reexamined the database for thrombectomies where 
an initial mTICI2b outcome could be subsequently upgraded to mTICI2c/3, 
finding 28 cases where the revascularization and consequently the clinical 
outcome was improved. Remarkably no difference between the primary or 
secondary groups of mTICI2c/3 results could be observed. 
Compared to an overall Cohen’s Kappa of 0.609 and an ICC of 0.845 that 
were reached by the readers of the Tung group for mTICI grading and a 
Cohen’s Kappa of 0.83 by the Liebeskind group, we calculated an overall 
Kappa of 0.706 and an ICC of 0.862. These data show a higher interrater 
agreement than in the results of Tung et al., possibly because of a clearer 
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definition of the grades of the eTICI compared to the mTICI scale. The 
novel score, being derived from the widely used mTICI score, appears 
very easy to implement and requires only minor changes in the daily 
routine of angiographic grading. 
As stated above and confirming the results of Liebeskind’s research group, 
higher eTICI scores reperfusion are associated with better clinical 
outcome, which represents a prerequisite for a model which includes the 
impact of the time factor. Both the admission to recanalization and the 
groin to recanalization time affect the probability of achieving a good 
outcome at 90 days (mRS 0 – 2) and this hold true for all successful eTICI 
reperfusion grades (eTICI2b50 - eTICI3). The longer the time to 
recanalization is, the lower the probability of attaining a favorable outcome 
is. This effect is more accentuated in high reperfusion scores (eTICI2c and 
eTICI3) and less pronounced in eTICI2b50 and eTICI2b67, although still 
noticeable (see figure 16 and 17). A considerable distinction between 
eTICI2b50/eTICI2b67 and eTICI2c/3 groups in relation to the probability 
of reaching a good clinical outcome can be determined, further confirming 
the results of Tung’s and Kaesmacher’s groups. Significantly this study 
shows a circa 10 % difference in probability of achieving a good outcome 
at 90 days when comparing eTICI2c and eTICI3, reinforcing the 
importance of high revascularization results. This is in contrast with the 
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data reported by Tung et al., yet a different definition of eTICI2c/mTICI2c 
was used in the two studies, as stated above. 
The model here presented might help to identify patients who might benefit 
from a further secondary improvement of the angiographic score, 
depending on age, time of groin puncture to actual recanalization and 
current eTICI revascularization score, thus increasing the probability of a 
favorable neurological outcome. For instance, younger patients with rapid 
interventions and an eTICI2b50/2b67 angiographic outcome would likely 
benefit from a proceeding in the intervention, with the goal of achieving a 
higher angiographic reperfusion grade and increasing the likelihood of a 
favorable neurologic outcome. As Kaesmacher’s research group reported, 
a secondary angiographic improvement from a mTICI2b to mTICI2c/3 
results leads to a benefit in clinical outcome. In the presented model 
patients with an eTICI2b50 or eTICI2b67 score which are improved to 
eTICI2c within 90 minutes of groin puncture to recanalization have an 
overall 50 % probability of achieving a favorable outcome. Likewise, this 
model could be of use in identifying cases where persisting in the 
intervention would not be convenient, despite a low revascularization 
grade, specifically in older patients with extended intervention times, 
considering the low chance of obtaining a favorable outcome. Additionally 
a higher number of stent retriever passes and a prolonged intervention 
time are linked with inferior recanalization percentages and greater rates 
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of complications, which must be considered in the evaluation of these 
patients as well (Behme et al. 2014; Spiotta et al. 2014).   
This study presents several limitations. The first of them is represented by 
the retrospective evaluation of prospectively acquired data from a single 
center. The angiographic grading was blinded to the clinical outcome. 
However, the neurological assessment was not blinded to the 
angiographic result. Moreover, the radiological reviewers also performed 
or assisted some of the endovascular interventions, which might have 
affected their evaluation. We tried to mitigate this possible bias by blinding 
them to the clinical results as well as having them discuss eventual 
discrepancies of evaluation in a joint meeting. However, the imaging was 
not examined by an independent laboratory. Unlike others, we included 
cases with anterior as well as posterior circulation occlusion, since in our 
opinion all LVO cases need a reperfusion grading and we performed the 
grading according to the percentage definitions of eTICI regarding the 
downstream territory distal to the initial occlusion site. In this regard the 
eTICi score seems feasible for the assessment of LVO of the posterior 
circulation as well as for isolated proximal occlusions of a M2-segment of 
the MCA.  Since the mTICI scale was not originally designed for the 
posterior circulation, this might have had an impact on our results. It is 
worth noticing that the regression analysis as well as the investigation of 
the time parameters was only performed for patients with an anterior 
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circulation stroke. The role of time was implied to be equal in the examined 
eTICI categories, which could possibly be an oversimplification, since the 
impact of time might vary depending on the volume of the initially 
reperfused territory. Another limiting factor of the eTICI is that the score 
does not include a categorization of large vessel occlusion site or of 
eloquent brain areas affected by the acute ischemic stroke. It is known that 
involvement of eloquent areas in stroke is a predictor of cognitive outcome 
(Munsch et al. 2016; Kallmes et al. 2018). These aspects might influence 
the outcome after mechanical thrombectomy and could represent 
interesting subjects of research in the future, perhaps leading to a score 
which includes the specific occlusion site or eloquent brain areas involved 
in the ischemic stroke, similarly to the Spetzler-Martin grading system in 
cerebral arteriovenous malformations (Spetzler and Martin 1986; Kallmes 
et al. 2018). More studies, ideally prospective, multicentric and including 
larger patient cohorts are necessary to validate the presented results.  
Several international research teams are currently investigating the 
possibilities of using a flat-detector CT-perfusion (FDCTP) directly in the 
angiography suite (Yang et al. 2015). This could be used for the pre-
interventional evaluation of stroke patients together with FDCT and FDCT-
Angiography when transferred directly to the angiography suite as well as 
for intra- and immediate post-interventional assessment of brain perfusion. 
During the trombectomy procedure the interventionalist might perform a 
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FDCTP to assess the extent of reperfusion in real time, which might differ 
from the revascularization, for instance in the case of revascularization of 
already infarcted brain parenchyma. This might also guide the 
interventionalist in carrying on the thrombectomy, like in the eventuality of 
persisting perfusion deficit in eloquent brain areas despite a good 
revascularization grade. The assessment of brain perfusion directly after 
the procedure (through an ASPECTS-Score or a dedicated new score) 
might correlate to neurological outcome more precisely than an 
angiographic revascularization score.     
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6 CONCLUSIONS 
 
Several recent randomized controlled trials have validated the major role 
of mechanical thrombectomy in the treatment of acute ischemic stroke. In 
summary, this study demonstrates the utility of the novel eTICI score, 
which expands the previous mTICI scale. This analysis shows that the 
eTICI score allows an overall better neurological outcome prediction 
compared to mTICI. Thereby granulation of the mTICI2b category into 
three more precise subdivisions (eTICI2b50, 2b67 and 2c) grants a more 
refined prediction of neurological outcome after thrombectomy of a large 
vessel occlusion compared to mTICI2b alone. This analysis also confirms 
the critical role of time in interventional stroke therapy and may provide a 
helpful tool in the management of patients with initial unfavorable 
angiographic score. Furthermore, this study corroborates that current 
endovascular reperfusion therapies allow for high recanalization rates and 
high rates of favorable clinical outcome. Moreover, higher degrees of 
recanalization of large vessel occlusion treated with mechanical 
thrombectomy result in greater neurological improvement and functional 
independence. Further multicentric trials may be necessary to investigate 
outcome prediction of the eTICI score on a larger cohort of patients as well 
as deepen our understanding of the role of time in interventional stroke 
treatment. 
 




Table 1.  The modified Ranking Scale (mRS) (Quinn et al. 2007). 
 
Table 2. The original TICI grading scale (Higashida et al. 2003). 
TICI grades Definitions 
Grade 0 No reperfusion 
Grade 1 Minimal reperfusion 
Grade 2a 
Only partial filling (less than 2/3) of the 
entire vascular territory 
Grade 2b 
Complete filling of all the expected 
vascular territory, but the filling is slower 
than normal 




0 No symptoms 
1 
No significant disability. Able to carry out all usual activities, 
despite some symptoms. 
2 
Slight disability. Able to look after own affairs without 
assistance, but unable to carry out all previous activities. 
3 
Moderate disability. Requires some help, but able to walk 
unassisted. 
4 
Moderately severe disability. Unable to attend to own bodily 
needs without assistance, and unable to walk unassisted. 
5 
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Table 3. The mTICI revascularization score (Zaidat et al. 2013, Ginsberg 2016). 
mTICI grades Definitions 
Grade 0 No reperfusion 
Grade 1 
Anterograde reperfusion past the initial occlusion, but limited distal 
branch filling with little or slow distal reperfusion 
Grade 2a 
Antegrade reperfusion of less than half (1 – 49 %) of the occluded 
target artery previously ischemic territory (e.g. in one major 
division of the middle cerebral artery and its territory) 
Grade 2b 
Antegrade reperfusion of more than half (50 – 99 %) of the 
previously occluded target artery ischemic territory (e.g. in two 
major divisions of the MCA and their territories) 
Grade 3 
Complete antegrade reperfusion (100 %) of the previously 
occluded target artery ischemic territory, with absence of 
visualized occlusion in all distal branches 
 
 
Table 4. The mTICI revascularization score with the 2c grade (Almekhlafi et al. 2014). 
Grade mTICI mTICI with 2c 
0/1 No / minimal reperfusion No / minimal reperfusion 
2a Partial filling < 50 % territory Partial filling < 50 % territory 
2b Partial filling  50 % territory Partial filling  50 % territory 
2c … 
Near complete reperfusion 
except slow flow or few distal 
cortical emboli 
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Table 5. The newly introduced expanded Treatment In Cerebral Ischemia (eTICI) 
revascularization score. 
eTICI score Definition 
eTICI0 No reperfusion 
eTICI1 
Reduced clot without reperfusion of 
distal branches 
eTICI2a 
1 – 49 % Anterograde reperfusion of the 
previously occluded target artery 
ischemic territory 
eTICI2b50 
50 – 66 % Anterograde reperfusion of 
the previously occluded target artery 
ischemic territory 
eTICI2b67 
67 – 89 % Anterograde reperfusion of 
the previously occluded target artery 
ischemic territory 
eTICI2c 
90 – 99 % Anterograde reperfusion of 
the previously occluded target artery 
ischemic territory 
eTICI3 
100 % Anterograde reperfusion of the 
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Table 6. Comparison of the newly introduced eTICI with the mTICI revascularization 
score. The mTICI2b grade is divided in 3 grades (2b50, 2b67 and 2c) in the eTICI 
score. 
Reperfusion mTICI eTICI 
No reperfusion 0 0 
Reduced clot without reperfusion 1 1 
1 – 49 % 2a 2a 
50 – 66 % 2b 2b50 
67 – 89 % 2b 2b67 
90 – 99 % 2b 2c 




Table 7. Clinical demographics, angiographic and procedural information of patients 
for the eTICI analysis (Behme et al. 2019). 
Item Median (IQR) or n (%) 
Age 76 (66-82) 
Initial NIHSS 16 (10-20) 
Male gender 109 (48.4 %) 
Female gender 116 (51.6 %) 
Site of occlusion  
Internal carotid artery (ICA) 64 (28.4 %) 
Middle cerebral artery (MCA) 132 (58.7 %) 
Tandem lesions (ICA + MCA) 44 (19.6 %) 
Basilar artery 24 (10.7 %) 
Posterior cerebral artery (PCA) 5 (2.2 %) 
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Procedural information  
Groin to recanalization time, min 50 (32-74) 
eTICI0 (mTICI0) 9 (4 %) 
eTICI1 (mTICI1) 4 (1.8 %) 
eTICI2a (mTICI2a) 22 (9.8 %) 
eTICI2b50 (mTICI2b) 23 (10.2 %) 
eTICI2b67 (mTICI2b) 71 (31.6 %) 
eTICI2c (mTICI2b) 46 (20.4 %) 
eTICI3 (mTICI3) 50 (22.2 %) 
Neurological outcome at 90days  
mRS0 26 (12 %) 
mRS1 32 (14 %) 
mRS2 30 (13 %) 
mRS3 27 (12 %) 
mRS4 31 (14 %) 
mRS5 22 (10 %) 
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Table 8. Classification of eTICI categories respectively to the clinical outcomes 
(measured with mRS at 90 days) for all patients of the study. 












































































































Table 9. Probability of good outcome at 90 days according to mTICI2b versus 
eTICI2b50-2c (Behme et al. 2019). 
 mRS=0,1,2 mRS=3,4,5,6 % (mRS=0,1,2) 
mTICI2b 44 78 36,06 % 
eTICI2b50 4 19 17,39 % 
eTICI2b67 17 54 23,94 % 
eTICI2c 25 21 54,34 % 
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Table 10. Demographics, angiographic and procedural information of patients for the 
time analysis of the eTICI scale (reproduced with permission of "Springer Nature"). 
Item Median (IQR) or n (%) 
Age 76 (66-82) 
Initial NIHSS 16 (10.5-20) 
Male gender 74 (45.1 %) 
Site of occlusion  
Internal carotid artery (ICA) 51/164 (31 %) 
Middle cerebral artery (MCA) 113/164 (69 %) 
Procedural information  
Admission to recanalization 97 min (76 - 116) 
Admission to groin puncture 47 min (29 - 63) 
Groin puncture to recanalization time 47 min (31 - 66) 
eTICI2b50  20 (12.2 %) 
eTICI2b67  60 (36.6 %) 
eTICI2c  38 (23.2 %) 
eTICI3  46 (28 %) 
Neurological outcome at 90days  
mRS 0 - 2  70 (42.7 %) 
mRS 3 - 6 94 (57.3 %) 
Favorable outcome (mRS 0 - 2)  
eTICI2b50 3/20 (15 %) 
eTICI2b67 11/60 (18.3 %) 
eTICI2c 22/38 (57.9 %) 
eTICI3 34/46 (73.9 %) 
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Table 11. Statistical analysis of admission to recanalization time (pt. 1) (Behme et al. 
2019, reproduced with permission of "Springer Nature"). 
Comparison (eTICI) p-value Odds ratio Lower CI Upper CI 
2b50 vs. 2b67 0.5744 1.569 0.326 7.546 
2b50 vs. 2c 0.0388 0.2 0.043 0.928 
2b50 vs. 3 0.0012 0.0073 0.015 0.358 
2b67 vs. 2c 0.0366 0.127 0.043 0.374 
2b67 vs 3 <0.0001 0.073 0.015 0.358 
2c vs. 3 0.0731 0.367 0.123 1.098 
 
 
Table 12. Statistical analysis of admission to recanalization time (pt. 2). The variables 
are the time of admission to recanalization and the patient’s age (Behme et al. 2019, 
reproduced with permission of "Springer Nature"). 
Variable p-value Odd-ratio Lower-CI Upper-CI Change per min. 
Admin. to rec. 0.2281 0.994 0.984 1.004 0.9939 
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Table 13. Statistical analysis of groin puncture to recanalization time (pt. 1) (Behme et 
al. 2019, reproduced with permission of "Springer Nature"). 
Comparison (eTICI) p-value Odds ratio Lower CI Upper CI 
2b50 vs. 2b67 0.5017 1.722 0.974 1.005 
2b50 vs. 2c 0.0392 0.197 0.042 0.923 
2b50 vs. 3 0.0016 0.077 0.016 0.379 
2b67 vs. 2c <0.0001 0.115 0.039 0.34 
2b67 vs 3 <0.0001 0.045 0.014 0.143 
2c vs. 3 0.0933 0.197 0.042 0.923 
 
Table 14. Statistical analysis of groin puncture to recanalization time (pt. 2). The 
variables are the time of groin puncture to recanalization and the patient’s age (Behme 
et al. 2019, reproduced with permission of "Springer Nature"). 
Variable p-value Odd-ratio Lower-CI Upper-CI Change per min. 
Groin to rec. 0.1713 0.989 0.974 1.005 0.9879 
Age 0.0139 0.955 0.921 0.991 0.9550 
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7.2 Figures 
 
Figure 1. The arterial circulation of the brain. The right temporal pole and a portion of 
the right cerebellar hemisphere have been removed (Gray 1918. Fig. 516. Public 
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Figure 2. A typical imaging of a patient affected by acute ischemic stroke with spiral 
computed tomography. A 79 years old patient presented with global aphasia and right-
sided hemiparesis. A: The non-contrast CT shows no early signs of infarction. B: In the 
maximum intensity projection (MIP) reconstruction of the CT-Angiography can be seen 
the abrupt cessation of contrast flow within the proximal portion of the middle cerebral 
artery (MCA), as an indirect sign of thrombotic occlusion. C: The CT-Perfusion depicts 
a CBF/CBV mismatch and a reduction of the other hemodynamic parameters, a sign 
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Figure 3. Graphic representation of the evolution of major techniques and devices in 
mechanical thrombectomy (Spiotta et al. 2015. Reproduced with permission of "BMJ 





Figure 4. The Solitaire FR stent retriever device (Castaño et al. 2016. Reproduced 
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Figure 5. Representation of the Stent retriever Assisted Vacuum-locked Extraction 
technique (SAVE). A: Initial angiogram shows an occlusion of the right middle cerebral 
artery (MCA). B: A 4 x 30 mm stent retriever (Trevo ProVue, Stryker Neurovascular, 
Kalamazoo, MI, USA) placed distally and across the thrombus (along the proximal 
third, white arrow). C, D and E: The aspiration catheter is advanced distally under 
continuous aspiration, until a wedge position is achieved. After the unit retrieval 
process, posterior-anterior and lateral angiograms (F and G) show the successful 
reperfusion of the right MCA-territorium. H: Thrombus incorporated in the proximal/ 
middle portion the stent retriever with a clot fragment caught by the distal end of the 




Figure 6. A large thrombus extracted with a stent retriever and partially incorporated 
in the distal portion of the device (Papanagiotou and White 2016. Reproduced with 
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Figure 7. Lateral and posterior-anterior (PA) views of large vessel occlusion (LVO) and 
eTICI2a (mTICI2a) reperfusion results. A and B show a right-sided, proximal occlusion 
of the middle cerebral artery (MCA). After mechanical thrombectomy (C and D) the 
distal portion of the right MCA remains occluded, while reperfusion of the right anterior 
temporal artery and of the right medial lenticulostriate arteries can be appreciated, 
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Figure 8. Lateral and posterior-anterior (PA) views of large vessel occlusion (LVO) and 
eTICI2b50 (mTICI2b) reperfusion results. A and B show a left-sided, proximal 
occlusion of the middle cerebral artery (MCA). Lateral and PA-views (C and D) after 
recanalization depict residual fronto-parieto-temporal occlusions in the left MCA-
territorium, rated as eTICI2b50 (mTICI2b). Please note that, since the LVO involves 
the left MCA, only the left MCA-territorium (and therefore not the anterior cerebral 
artery vascular territory) must be evaluated with eTICI.  
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Figure 9. Lateral and posterior-anterior (PA) views of large vessel occlusion (LVO) and 
eTICI2b67 (mTICI2b) reperfusion results. A and B show a left-sided, distal occlusion 
of the internal carotid artery (ICA). Lateral and PA-views (C and D) after recanalization 
depict residual frontoparietal occlusions in the left anterior- and media-territorium, rated 
as eTICI2b67 (mTICI2b). Please note that, since the LVO involves the left ICA, both 








 - 68 - 
Figure 10. Lateral and posterior-anterior (PA) views of large vessel occlusion (LVO) 
and eTICI2c (mTICI2b) reperfusion results. A and B show a distal occlusion of the right 
internal carotid artery (ICA). In the lateral and PA-views (C and D) after recanalization 
only very small, distal parietal branches do not fill with contrast medium. The result was 
rated eTICI2c (mTICI2b). As noted before, since the LVO involves the right ICA, both 
the right anterior and media vascular territory must be evaluated in the eTICI analysis. 
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Figure 11. Circle chart illustrating the distribution of the large vessel occlusions (LVO) 
included in the study.  The majority of the LVO were located in the anterior circulation 
(ICA, MCA and tandem lesions), while thrombotic occlusions of proximal vessels of the 
posterior circulation (Basilar artery and PCA) represented ca. 13 % of the LVO. 
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Figure 12. Bar chart depicting reperfusion outcomes classified with the eTICI scale. 
Reperfusion of 50 % or more of the previously ischemic territory was achieved in more 
than 84 % of cases. Complete reperfusion was achieved in almost one fourth of the 
patients (22.2 %). Reperfusion of 50-99 % of ischemic territory (eTICI2b50, eTICI2b67 
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Figure 13. Bar chart representing the neurological outcome after mechanical 
thrombectomy, measured with modified Ranking Scale (mRS) at 90 days. Favorable 
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Figure 14. Graphic representation of neurological outcome (mRS at 90 days) after 
thrombectomy, depending on revascularization score, evaluated with the eTICI scale. 
Several distinctive trends can be observed. Most importantly with the improvement of 
the revascularization outcome (eTICI0 to 3), a progressive higher percentage of 
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Figure 15. Receiver operating characteristic (ROC) curve for eTICI and mTICI. 
Comparison of both ROC curves for the prediction of good functional outcome (mRS 
0 – 2) at 90 days (Behme et al. 2019). 
 
 
Figure 16. Analysis of time of admission to recanalization A: probability of achieving 
good outcome according to angiographic reperfusion grade, measured with eTICI. The 
x-axis shows the admission to recanalization time (in minutes) while the y-axis displays 
the probability of good outcome at 90 days (mRS 0-2). B: Log odds for attaining a good 
outcome at 90 days (mRS 0-2) depending on eTICI reperfusion grade. x-axis: time in 
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Figure 17. Analysis of time of arterial groin puncture to recanalization A: probability of 
achieving good outcome (mRS 0-2 at 90 days, y-axis) according to eTICI grade 
(colored lines) and depending on the groin to recanalization time (x-axis). B: Log odds 
for attaining a good outcome at 90 days (mRS 0-2) depending on eTICI reperfusion 
grade (colored lines). x-axis: time in minutes, y-axis: log odds (Behme et al. 2019, 
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